top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Potential Health Benefits of Fruits and Vegetables II
Potential Health Benefits of Fruits and Vegetables II
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2023
Descrizione fisica 1 online resource (200 p.)
Soggetto topico Biology, life sciences
Research & information: general
Technology, engineering, agriculture
Soggetto non controllato Acer mono Maxim
allosteric binding site
anthocyanins
antimycobacterial
antioxidant activity
antioxidant capacity
bactericidal activity
beetroot
berry volatiles
betalain
bioavailability
biomolecules
biosynthesis
black cabbage
botanicals
broccoli
Bromelia karatas
carotenoids
casp9
chemical composition
chlorophylls
clinical trial
color
colorant
colorectal cancer
depression
dyslipidemia
folate
freeze-drying
grik1
health benefits
hepatocellular carcinoma
herbs
in vivo
isocitrate lyase
isocoumarins
itaconic anhydride
LAB
Lactobacillus paracasei
maleic anhydride
molecular dynamics
multidrug resistance
n/a
neuro-behavioral test
non-competitive inhibitor
nutritional quality
oleamide
oral administration
pigmented potatoes
pigments
plant portion
polyphenols
principal component analysis (PCA)
probiotics
protein hydrolysates
proximate composition
red bell pepper
resistance mechanisms
safflower
Sambucus nigra
sensorial quality
Solanum tuberosum
stage development
storage
strawberry
total phenols
transcriptome
tropical plants extracts
vegetable and fruit juice
vegetables
vitamin C
β-glucuronidase
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9911053058103321
MDPI - Multidisciplinary Digital Publishing Institute, 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Tuberculosis Drug Discovery and Development 2019
Tuberculosis Drug Discovery and Development 2019
Autore Riccardi Giovanna
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (296 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato anti-TB drug pipeline
anti-virulence compounds
antibiotic
antimicrobial drug resistance (AMR)
antimycobacterial
antituberculosis agents
artificial pneumothorax
BCG
bedaquiline
biomarkers
Carlo Forlanini
caseum
cell envelope
clinical studies
clinical trial
CTVD
delpazolid
discovery
DNA gyrase
dormancy
DprE1 inhibitor
drug combination
drug development
drug discovery
drug resistance
drug-drug interactions
EDCTP
electron transport chain
energy metabolism
genomics
granulomas
host-directed therapy
IAVI
in vitro
in vivo
isoniazid
lead generation
lipidomics
macozinone
mechanism of action
mechanisms of resistance
metabolomics
MID3
mode of action
multi-drug resistance
mutations
mycobacteria
mycobacterium
Mycobacterium tuberculosis
n/a
oxidative phosphorylation
pharmacodynamics
pharmacokinetics
phenotypic screening
PknB
PknG
post-treatment sequelae
privileged targets
promiscuous targets
proteomics
pulmonary rehabilitation
Q203
rifampin
structure-based drug design
surgery
target
target identification
target-based drug design
target-based screening
TB
TBVI
toxicity
transcriptomics
tuberculosis
tuberculosis treatment
tuberculosis vaccines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557627203321
Riccardi Giovanna  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui